Rupee rises 3 paise to 88.69 against U.S. dollar in early trade

Rupee rises 3 paise to 88.69 against the U.S. dollar in early trade on Monday (September 29, 2025), tracking positive Asian currencies and weakness of the American currency in the overseas market.

Forex traders said the rupee is trading in a tight range as it remains under pressure influenced by continued capital outflows and geo-political developments.

Moreover, the RBI policy meeting outcome on October 1, is expected to influence the rupee and government bond movements.

At the interbank foreign exchange market the rupee opened at 88.69 against the U.S. dollar, registering a gain of 3 paise from its previous close. On Friday (September 26, 2025), the rupee rebounded from its all-time low to close 4 paise higher at 88.72 against the U.S. dollar.

The rupee fell to a fresh lifetime low of 88.76 against the American currency on Thursday (September 25, 2025).

“The RBI may intervene to keep rupee within the 88.80 level as market watchers closely monitor the impact of U.S. tariffs and external capital flows on the currency,” said Anil Kumar Bhansali, Head of Treasury and Executive Director Finrex Treasury Advisors LLP.

Meanwhile, the dollar index, which gauges the greenback’s strength against a basket of six currencies, was trading at 97.94, lower by 0.21%. Brent crude, the global oil benchmark, was trading 0.58 per cent lower at $69.72 per barrel in futures trade.

Forex traders said persistent foreign fund outflows and risk-off sentiment prevented a sharp rise in the domestic unit, while hopes of a breakthrough on the US tariff front weighed on investor sentiments.

On the domestic equity market front, equity markets rebounded in early trade with Sensex climbing 255.46 points to 80,681.92 and Nifty rising 89.05 points to 24,743.75.

Foreign Institutional Investors offloaded equities worth ₹5,687.58 crore on Friday (September 26, 2025), according to exchange data.

Meanwhile, the U.S. has announced the imposition of a 100 per cent tariff on branded or patented drugs entering the U.S. from October 1, except for pharmaceutical companies building manufacturing plants in the U.S.

The exemption covers projects where construction has started, including sites that have broken ground or are under construction.

India’s forex reserves dropped by $396 million to $702.57 billion for the week ended September 19, according to the RBI data.

In the previous reporting week, the overall reserves had jumped by $4.698 billion to $702.966 billion.